|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash Flows from Operating Activities: | |||
| Net income (loss) | |||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities, net of acquisitions: | |||
| Depreciation and amortization | |||
| Loss on debt extinguishment | |||
| Change in fair value of Legacy Bridger Series A Preferred Shares | |||
| Interest accrued on Legacy Bridger Series B Preferred Shares | |||
| Impairment of long-lived assets | |||
| Stock-based compensation expense | |||
| Change in fair value of Warrants | |||
| Amortization of debt issuance costs | |||
| Loss on termination of interest rate swap | |||
| Reclassification of realized gain on derivative instruments from AOCI | |||
| Change in fair value of earnout consideration | |||
| (Gain) loss on disposal of fixed assets | |||
| Change in fair value of embedded derivative | |||
| Change in fair value of freestanding derivative | |||
| Realized gain on investments in marketable securities | |||
| Deferred tax benefit | |||
| Changes in operating assets and liabilities, net: | |||
| Accounts receivable | |||
| Aircraft support parts | |||
| Prepaid expense and other current and noncurrent assets | |||
| Accounts payable, accrued expenses and other liabilities | |||
| Net cash provided by operating activities | |||
| Cash Flows from Investing Activities: | |||
| Sale of property, plant and equipment | |||
| Capitalized costs related to in-process research and development (“IPR&D”) | |||
| Issuance of note receivable | |||
| Investments in construction in progress - buildings | |||
| Purchases and improvements of property, plant and equipment | |||
| Proceeds from sales and maturities of marketable securities | |||
| Purchases of marketable securities | |||
| Investment in equity securities | |||
| Collection of note receivable | |||
| Cash acquired through acquisition | |||
| Net cash (used in) provided by investing activities | |||
| Cash Flows from Financing Activities: | |||
| Costs incurred related to the Closing | |||
| Proceeds from the Closing | |||
| Proceeds from issuance of term loans | |||
| Payment of issuance costs for term loans | |||
| Termination of interest rate swap | |||
| Payment of finance lease liability | |||
| Payment to Legacy Bridger preferred shares members | |||
| Proceeds from issuance of redeemable preferred stock | |||
| Borrowings from 2022 taxable industrial revenue bond | |||
| Extinguishment of 2021 Taxable Industrial Revenue Bond | |||
| Borrowings from vehicle loans | |||
| Cash paid for taxes related to net share settlement of equity awards | |||
| Repayments on debt | |||
| Payment of issuance costs for Common Stock in offerings | |||
| Proceeds from issuance of Common Stock in the at-the-market offering | |||
| Proceeds from issuance of Common Stock in the registered direct offering | |||
| Net cash (used in) provided by financing activities | |||
| Effects of exchange rate changes | |||
| Net change in cash, cash equivalents and restricted cash | |||
| Cash, cash equivalents and restricted cash – beginning of the year | |||
| Cash, cash equivalents and restricted cash – end of the year | |||
| Less: Restricted cash – end of the year | |||
| Cash and cash equivalents – end of the year |
Loading...
